Evidence map›Paper›PMID 18987909›Full record

ArticleAbdominal imaging2010

New insight of pancreatic imaging: from "unexplored" to "explored".

Hiromu Mori

Open access · hybridAbstract read
In one paragraph

Article in Abdominal imaging, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Hiromu MoriDepartment of Radiology, Faculty of Medicine, Oita University, Yufu-City, Oita, Japan. morihrmu@med.oita-u.ac.jp
Oita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer remains one of the most difficult neoplasms for early diagnosis and treatment. Recent advances of imaging including 3D volume data setting in multidetector-row CT (MDCT) and MRI are urging us to focus on the imaging of normal and pathological conditions of pancreatic parenchyme and peripancreatic structures, which are frequently involved by pancreatic cancers and are affecting the prognosis of patients with pancreatic cancers. In this Feature Section, five main topics of pancreatic imaging are addressed: pancreatic arterial territories, imaging of the intra- and peripancreatic venous anatomy and its clinical significance, imaging of the peripancreatic lymphatic network and its clinical significance for staging of pancreatic cancer, perfusion characteristics of pancreatic cancer to differentiate chronic mass-forming pancreatitis, and development of intraductal papillary mucinus neoplasms of the pancreas (IPMNs) to adenocarcinoma and pancreatic invasion. Recognition and understanding of the imaging anatomy of the pancreas might lead to precise staging of pancreatic cancer and to new approaches of less-invasive treatment. Follow-up of patients with IPMNs of the pancreas on imaging seems, at this time, to be the most valuable strategy in the high-risk group selection.

Indexed as

Diagnosis, DifferentialHumansImaging, Three-DimensionalLymph NodesMagnetic Resonance ImagingNeoplasm InvasivenessNeoplasm StagingPancreasPancreatic NeoplasmsTomography, X-Ray Computed

Identifiers

PMID18987909
PMCPMC2852030
OpenAlexW1997127856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.